Accelerating the transition of regenerative medicine technologies to the global market.
RegenMed Development Organization (ReMDO) is a 501(c)3 non-profit with a mission to help deliver on the promise of regenerative medicine by conducting research to de-risk technologies, promoting progress of biomanufacturing scale-up and automation to make technologies more affordable, and speeding up the translation to clinical practice.
ReMDO is advancing these goals through the following initiatives:
The mission of the Organization within the above stated purposes is to accelerate the discover and development of applications of new therapies for disease and translate those therapies into treatments for patients through the science of regenerative medicine. ReMDO will have a focus on obtaining federal grant funds and then deploying those funds to other organizations developing regenerative medicine therapies and products.
ReMDO’s Vision is to use this manufacturing ecosystem to nurture the development of regenerative medicine technologies, partners working together to improve patient outcomes and usher in new breakthrough capabilities in health care.
A leading resource in the field, Stem Cells Translational Medicine, with its publishing headquarters in North Carolina, is the official journal for RMMS.